By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneNews has extended the term of certain purchase warrants to July 31, 2012.

The warrants were issued by the Canadian molecular diagnostics firm on Jan. 16, 2009 and Feb. 11, 2009, entitling holders to purchase one common share of GeneNews at an exercise price of C$.25 ($US.25) per share.

There are 1 million warrants that were set to expire on Jan. 16, 2012, and there are 1,978,065 warrants that were set to expire on Feb. 11, 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.